Back

Artery Tertiary Lymphoid Organs (ATLOs) encode a pathogenic high affinity autoantibody driving atherosclerosis

29 August 2026 (09:05 - 09:15)
Organised by: Logo
Congress Presentation Part of: Vascular ageing and atherosclerosis Leukocytes, Inflammation, Immunity ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Changjun Yin

First Affiliated Hospital of Sun Yat-sen University, Guangzhou (China)

5 More presentations in this session

Presentation thumbnail
Beyond typical lipid suspects - identification of sphingolipid metabolism as a pharmacotherapeutic target in calcific aortic valve disease
Mr T. Rusack (Luebeck, DE)
Abstract Slides
Presentation thumbnail
Let-7b-5p protects against aortic dissection by inhibiting inflammatory vascular smooth muscle cell PANoptosis
Assistant Professor H. Lu (Taipei, TW)
Abstract Slides
Presentation thumbnail
Excessive fatty acid oxidation drives lipotoxic vascular aging: therapeutic targeting of the PPAR-α/CPT1A Axis by betulinic acid
Professor F. Cao (Beijing, CN)
Abstract Slides
Presentation thumbnail
Genome wide associations with silent atherosclerosis
Doctor R. Hasselbalch (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Endothelin‑1 clearance by endothelin‑B receptor–expressing LYVE1⁺ macrophages limits cardiometabolic disease progression
Doctor S. Mause (Aachen, DE)
Abstract Slides

Access the full session

Session thumbnail
Vascular ageing and atherosclerosis
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 09:05 CET
You may be interested in
thumbnail
Congress Presentation
A single-cell atlas of immune checkpoint molecules in atherosclerosis in ApoE-/- mice
28 August 2023
thumbnail
Congress Presentation
Characterization of AT-02, a pan-amyloid-binding peptide fusion immunoglobulin with high binding potency, complement activation, and immune cell stimulation
27 August 2023
thumbnail
Congress Presentation
Autoantibodies directed against apolipoprotein-a-1 as a potential contributor to non-alcoholic fatty liver disease
27 August 2021
thumbnail
Congress Presentation
Adaptive antimyocardial immune response following hospitalization for acute heart failure predicts 18-month prognosis
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources